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Colonoscopy is regularly used for investigation of bowel pathology 
and has become the gold standard for screening and diagnosis 
of colorectal cancer (CRC).[1] The procedure has diagnostic and 
therapeutic benefits, such as direct visualisation of the entire colon 
and removal of precancerous polyps, which is associated with a 
lowered risk of CRC.[2] Colonoscopy is a skill-intensive procedure 
and poses a risk to the patient, even if performed by a trained 
endoscopist in an appropriate setting.[1] Therefore, there is a need 
for standardised practice and regular audit of endoscopists to ensure 
consistent, high-quality care.[3] 
Based on the ‘adenoma-carcinoma sequence’ hypothesis for 
developing CRC, screening and surveillance colonoscopy aim to 
detect and remove polyps, particularly adenomatous polyps, with 
the intention of reducing the incidence of CRC.[4] Therefore, the 
polyp detection rate (PDR) and adenoma detection rate (ADR) are 
two key indicators of the quality of endoscopy. Other measurable 
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Background. In South Africa, there are no national guidelines for the conduct or quality assessment of colonoscopy, the gold standard for 
investigation and diagnosis of bowel pathology. 
Objectives. To describe the clinical profile of patients and evaluate the practice of colonoscopy using procedural quality indicators at the 
Wits Donald Gordon Medical Centre (WDGMC) outpatient endoscopy unit (OEU). 
Methods. We conducted a prospective, clinical practice audit of colonoscopies performed on adults (≥18 years of age). A total of 1 643 patients 
were included in the study and variables that were collected enabled the assessment of adequacy of bowel preparation, length of withdrawal 
time and calculation of caecal intubation rate (CIR), polyp detection rate (PDR) and adenoma detection rate (ADR). We stratified PDR and 
ADR by sex, age, population group, withdrawal time and bowel preparation. CIR, PDR and ADR estimates were compared between patient 
groups by the χ2 test; Fisher’s exact test was used for 2 × 2 tables. A p-value <0.05 was used. Benchmark recommendations by the American 
Society for Gastrointestinal Endoscopy (ASGE)/American College of Gastroenterology (ACG) Task Force on Colorectal Cancer (CRC) were 
used in this audit to assess individual endoscopist performance and that of the endoscopy unit as a whole.
Results. The mean age of patients was 55.7 (standard deviation (SD) 14.4; range 18 - 91) years, ~60% were female, and the majority (75.5%) 
were white. Of the outpatients, 77.6% had adequate bowel preparation (ASGE/ACG benchmark ≥85%). The CIR was 97.0% overall, and 
screening colonoscopy was 96.3% (ASGE/ACG benchmark ≥90% overall and ≥95% for screening colonoscopies). The median withdrawal 
time for negative-result screening colonoscopies was 5.7 minutes (interquartile range (IQR) 4.2 - 9.3; range 1.1 - 20.6) (ASGE/ACG 
benchmark ≥ 6minutes), and PDR and ADR were 27.6% and 15.6%, respectively (ASGE/ACG benchmark ADR ≥25%). We demonstrated 
a 23.7% increase in PDR and 14.1% increase in ADR between scopes that had mean withdrawal times of ≥6 minutes and <6 minutes, 
respectively. Although the number of black Africans in the study was relatively small, our results showed that they have similar ADRs and 
PDRs to the white population group, contradicting popular belief. 
Conclusions. The WDGMC OEU performed reasonably well against the international guidelines, despite some inadequacy in bowel 
preparation and lower than recommended median withdrawal times on negative-result colonoscopy. Annual auditing of clinical practice 
and availability of these data in the public domain will become standard of care, making this audit a baseline for longitudinal observation, 
assessing the impact of interventions, and contributing to the development of local guidelines.
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factors, such as adequate bowel preparation, reaching the caecum or 
terminal ileum and scope withdrawal time, all affect the clinician’s 
ability to detect polyps and should be scrutinised alongside ADR 
and PDR.[2,5] Unfortunately, there are no locally derived guidelines 
or benchmarks for measurement of quality of colonoscopy in 
South Africa (SA). International guidelines, such as the American 
Society for Gastrointestinal Endoscopy (ASGE)/American College 
of Gastroenterology (ACG) Task Force on Colorectal Cancer can be 
used to benchmark our performance as a unit and that of individual 
endoscopists.[6] 
Wits Donald Gordon Medical Centre (WDGMC) in Johannesburg, 
SA is part of the University of the Witwatersrand academic teaching 
hospital complex and was the first private academic hospital in SA. 
In 2006, a formal outpatient endoscopy unit (OEU) was established 
that currently hosts 14 endoscopists. All endoscopists have medical 
or surgical specialist training in endoscopy. In this audit, we aimed 
to describe the clinical profile of patients undergoing colonoscopy at 
WDGMC and to evaluate the practice of colonoscopy in the OEU by 
assessing intraprocedural quality indicators.
Methods
We conducted a prospective, clinical practice audit of colonoscopies 
performed on adults (≥18 years of age) between 1 March 2018 and 
28 February 2019 at the WDGMC OEU. Each endoscopist agreed to 
participate in the audit, and we obtained written informed consent 
from all patients. The attending nurse collected details of the 
colonoscopy at the time of the procedure using a standardised data 
collection sheet (Appendix A: http://samj.org.za/public/sup/14419-a.
pdf) and data were imported into REDCap (Research Electronic Data 
Capture).[7] Bowel preparation prior to colonoscopy was prescribed 
according to the endoscopist’s preference and was not standardised for 
the OEU. Adequacy of bowel preparation at the time of colonoscopy 
was assessed by the endoscopist using a non-standardised score, 
graded as: (i) good; (ii) fair; (iii) poor; and (iv) bad. The variables 
collected enabled the calculation of caecal intubation rates (CIR) and 
PDR. We did not record any information on size, grade, histological 
type, morphology and anatomical location of polyps or detail 
regarding the technique of removal (biopsy v. endoscopic mucosal 
resection). To calculate ADR, histological reports were accessed 
to confirm whether polyps were adenomatous. In the analysis, we 
further stratified PDR and ADR by sex, age, population group, 
withdrawal time and bowel preparation. We analysed data overall and 
per endoscopist if a minimum of 50 colonoscopies were performed 
during the review period. 
Definitions
CIR: number of colonoscopies where the caecum or terminal ileum 
was reached, divided by the number of colonoscopies where the 
intended endpoint was the caecum or terminal ileum; PDR: number 
of screening colonoscopies in which polyps were detected, divided by 
the total number of screening colonoscopies; and ADR: number of 
screening colonoscopies in which an adenoma was detected, divided 
by the total number of screening colonoscopies. 
Benchmarks
CIR: ≥90% overall, and ≥95% for screening coloscopies; adequate 
outpatient bowel preparation rate: ≥85%; average withdrawal time for 
negative-result screening colonoscopies: ≥6 minutes; ADR: ≥25% over all 
(≥30% for men and ≥20% for women);[2] PDR: ≥40% for men and 
≥30% for women (there is no definitive benchmark for PDR from 
the ASGE/ACG Task Force or other governing bodies, such as the 
British Society of Gastroenterology (BSG) or the Joint Advisory 
Group on gastrointestinal endoscopy (JAG). However, Williams et al.[8] 
concluded that a PDR of ≥40% for men and ≥30% for women was the 
minimum requirement to yield an ADR of >25% and >15% for men 
and women, respectively.[7,9]
Data analysis
CIR, PDR and ADR estimates were compared between patient groups 
by the χ2 test; Fisher’s exact test was used for 2 × 2 tables. Data analysis 
was done using SAS version 9.4 for Windows (Microsoft, USA). 
A p-value <0.05 was used. 
Ethical approval
The study was approved by the Human Research Ethics Committee 
(Medical) of the University of the Witwatersrand (ref. no. M171142).
Results 
Demographic characteristics of patients undergoing 
colonoscopy 
We recruited 1 643 patients from 1 March 2018 to 28 February 2019; 
their demographic characteristics are summarised in Table 1. The 
mean age of patients was 55.7 (standard deviation (SD) 14.4; range 18 - 
91) years, ~60% were female and the majority (75.5%) were white. 
Although this is an outpatient unit, 9.1% were hospital inpatients 
referred for colonoscopy to the OEU.
Indications for colonoscopy 
The most common indications for colonoscopy were screening 
(41.7%), polyp surveillance (9.7%) and cancer surveillance (8.7%) 
(Table 2). 
Quality indicators for colonoscopy
Overall and screening CIR, adequacy of bowel preparation and 
withdrawal time on screening colonoscopy are shown in Table 3. 
Table 1. Demographic characteristics of outpatients undergoing 
colonoscopy at Wits Donald Gordon Medical Centre 
Characteristic 
All colonoscopies 





18 - 39 239 (14.6) 43 (6.3)
40 - 49 266 (16.2) 115 (16.8)
50 - 59 407 (24.8) 204 (29.7)
60 - 69 440 (26.8) 217 (31.6)
70 - 79 248 (15.1) 93 (13.6)
≥80 43 (2.6) 14 (2.0)
Sex  
Male 688 (41.9) 276 (40.2)
Female 955 (58.1) 410 (59.8)
Population group   
White 1 241 (75.5) 543 (79.2)
Indian/Asian 225 (13.7) 74 (10.8)
Black 131 (8.0) 54 (7.9)
Mixed race 40 (2.4) 12 (1.7)
Other 4 (0.2) 2 (0.3)
Missing 2 (0.1) 1 (0.1)
Outpatient/inpatient status   
Outpatient 1 489 (90.6) 620 (90.5)
Inpatient 150 (9.1) 64 (9.3)
Missing 4 (0.2) 2 (0.3)
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For screening colonoscopies, PDR and ADR stratified by sex, popula-
tion group and withdrawal time are described in Table 4. Benchmarks 
for each quality indicator were included, where available.[2] We demon-
strated a 23.7% increase in PDR and 14.1% increase in ADR between 
scopes that had mean withdrawal times of ≥6 min utes and <6 minutes. 
Of the 686 screening colonoscopies performed, 176 polyps/speci-
mens were sent for histological analysis, and in these, 1 malignancy 
was diagnosed (grade 1 neuroendocrine tumour).
We were able to compare the performance of 10 of the 14 endos-
copists who participated in the study – each had completed 
>50 colon os copies during the study period. All of these endoscopists 
achieved an overall CIR above the benchmark of 90%; half (5/10) 
met the benchmark of ≥95% for screening colonoscopies; 2 achieved 
the ≥85% benchmark for adequate outpatient bowel preparation; 
3 had a median withdrawal time of ≥6 minutes for negative-result 
screening colonoscopies; and only 1 met the benchmark of ≥40% 
and ≥30% for men and women, respectively, for PDR, and ≥25% 
for ADR.
Table 2. Indications for colonoscopy
Indication* n (%) (N=1 643)
Screening 686 (41.7)
Polyp surveillance 160 (9.7)
Cancer surveillance 142 (8.7)
Change in bowel habits 135 (8.2)
Investigation of diarrhoea 108 (6.6)
Rectal bleeding 93 (5.7)
Anaemia 83 (5.1)
Abdominal pain 82 (5.0)
Inflammatory bowel disease surveillance 75 (4.6)




*More than one indication per procedure is possible.
Table 3. Quality indicators
Quality indicator n/N (%)* Benchmark
Caecal intubation rate 
All colonoscopies 1 582/1 631 (97.0) ≥90%
Screening colonoscopies only 659/684 (96.3) ≥95%
Good/fair bowel preparation
All colonoscopies 1 248/1 642 (76.0) -
Outpatients 1 155/1 448 (77.6) ≥85%
Inpatients 92/150 (61.3) -
Withdrawal time on screening 
Time (min.), median (IQR; range) (n=628) 6.3 (4.2 - 9.3; 1.1 - 43.3) -
<6 min. 284/628 (45.2) -
≥6 min. 344/628 (54.8) -
≥8 min.† 214/628 (34.1) -
Time for negative-result screening colonoscopies (min.), median (IQR; range) (n=458) 5.7 (4.2 - 9.3; 1.1 - 20.6) ≥6 min.
IQR = interquartile range.
*Unless otherwise indicated.
†Subset of ≥6 min.
Table 4. Polyp and adenoma detection rates for screening colonoscopies
                         Polyp detection rate Adenoma detection rate
n/N (%) p-value Benchmark, % n/N (%) p-value Benchmark, %
Overall 186/685* (27.2) - 107/686 (15.6) ≥25
Sex
Male 100/276 (36.2) 0.0001 ≥40 56/276 (20.3) 0.0071 ≥30
Female 86/409 (21.0) ≥30 51/410 (12.4) ≥20
Population group†
White 149/542 (27.5) 0.76 - 83/543 (15.3) 0.75 -
Indian/Asian 19/74 (25.7) - 13/74 (17.6) -
Black 17/54 (31.5) - 10/54 (18.5) -
Withdrawal time
<6 min. 40/284 (14.1) - 21/284 (7.4) -
≥6 min. 130/344 (37.8) <0.0001
(v. <6 min.)
- 74/344 (21.5) <0.0001
(v. <6 min.) 
-









*One polyp was reported as unknown and therefore excluded from the polyp detection rate calculation.
†Where n>30.
‡Subset of ≥6 min.
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Discussion
This preliminary clinical audit was our first attempt to evaluate 
the practice of colonoscopy in the OEU, with results proving 
promising for the future performance of the unit. It was expected 
that the majority of the scopes would be for screening (41.7%), 
surveillance for polyps (9.7%) and cancer (8.7%), as some of the 
endoscopists perform screening colonoscopies as part of the standard 
requirements for liver transplantation (WDGMC runs the largest 
liver transplant programme and has one of the largest oncology 
units in SA). Additionally, international guidelines recommend 
screening colonoscopy for those >50 years of age.[2] Therefore, it is 
reasonable that, when compared with an audit from Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) and international audits 
from Canada, the UK and Greece, the proportion of screening 
colonoscopies done at WDGMC was almost double (WDGMC: 
41.7% v. 9.7% - 28.7%).[1,5,10-12]
When assessing the key quality indicators of screening 
colonoscopies, results showed that our PDR (27.2%) and ADR 
(15.6%) were low compared with international benchmarks and 
published data from high-income countries. These studies reported 
PDRs between 32.1% and 59.7%, and ADRs between 27.1% and 
54.0%.[1,10,13-15] The obvious explanation might be that our patient 
profile is different, requiring locally derived, population-appropriate 
benchmarks for South Africans and, preferably, the sub-Saharan 
African (sSA) region. While a small proportion of patients in this 
clinical audit were black Africans, it is noteworthy that PDRs and 
ADRs for this group were similar to those of other population 
groups, despite the historical belief that black Africans ‘do not get 
polyps’.[16] When compared with neighbouring countries, a study from 
Harare, Zimbabwe reported polyps in 5% of black Zimbabweans 
compared with 8% of white Zimbabweans.[17] Studies from Zambia 
and Nigeria reported overall PDRs of 10% and 7.4%, respectively.[18,19] 
Unfortunately, none of the studies from our region reported ADRs, as 
very few of the colonoscopies performed were true screening scopes. 
For the same reason, these PDRs must be interpreted with caution. 
The audit from CMJAH reported a PDR of 25.2%, which is similar to 
our PDR of 27.2%.[5] Overall, the higher PDR reported for different 
sites in Johannesburg – the largest and wealthiest urban metropole 
in the country – might reflect relative affluence, and evidence of an 
epidemiological sociodemographic transition from rural to urban 
living for its residents, with associated dietary and lifestyle changes. 
SA might be at a more advanced stage of this transition than other sSA 
countries. Interestingly, it is well documented that African Americans, 
who have similar genetic origins to black Africans, have a higher 
prevalence of polyps than their white counterparts, suggesting a gene-
environment interaction that might alter clinical phenotypes.[20]
Alternatively, we could also question the quality of our clinical 
practice. Average withdrawal times >6 minutes were significantly 
associated with higher PDR/ADR and our withdrawal time on negative-
result screening colonoscopies was just under the recommended target 
of ≥6 minutes. Although some endoscopists challenge the association 
between withdrawal times and PDR/ADR (as increasing withdrawal 
time alone will not improve an ADR/PDR that is already adequate), 
data suggest that longer withdrawal times are strongly associated with 
an increase in PDR and ADR, particularly when endoscopists do not 
achieve accepted benchmarks.[1,13,19,21] 
Another factor that could have affected our PDR/ADR was the 
adequacy of our outpatient bowel preparation, which was below the 
ASGE/ACG Task Force benchmark of ≥85%. Interestingly, our results 
showed that inadequate bowel preparation yielded similar PDRs and 
ADRs to adequate bowel preparation, which could indicate that we 
are ‘over-calling’ poor bowel preparation as opposed to it actually 
being inadequate.[1,2] This could be owing to our clinicians not 
prescribing a standardised bowel preparation product or not using 
the same bowel preparation assessment tool when reporting the 
adequacy of this metric. 
Despite not meeting the benchmark for bowel preparation, CIR was 
above the ASGE/ACG Task Force recommendation of ≥90% for all 
colonoscopies and ≥95% for screening colonoscopies. International 
audits from Canada, the UK and New Zealand report CIRs on par 
with ours.[1,11,13] It must be noted that in our calculation of CIR, we 
accounted for the starting intention of the colonoscopy, whereas other 
studies could have used the total number of screening colonoscopies, 
regardless of the intention. Other audits from SA report variable 
CIRs, both above and below the ASGE/ACG benchmark.[5,22]
As part of the continuation of this audit in years to come, we shared 
our overall results with all healthcare workers in the OEU, which 
stimulated productive discussion regarding areas for improvement 
and additional variables for inclusion. For example, we will implement 
the Harefield cleansing scale for assessing bowel preparation.[23] For 
results per endoscopist, the clinicians requested open sharing of 
their data in an anonymised format. Each endoscopist also received 
a confidential report of their performance metrics. The published 
literature suggests that confidential feedback to each individual on 
their metrics, without unit-wide intervention, makes a difference 
to PDR and withdrawal time.[24-26] On this basis, the endoscopists 
at WDGMC agreed to use results from this audit as a baseline for 
comparison in the next annual audit. The annual report is accessible 
in the public domain. 
Study limitations
This audit is limited by the patient pool, as it reflects an urban, single-
centre experience of health-insured individuals, and our findings 
may not be generalisable. The sample may be biased because the OEU 
screens all patients receiving liver transplants at WDGMC. Therefore, 
the screening population may not be average-risk asymptomatic 
individuals. There are no national guidelines or benchmarks for 
South Africans, or for different population groups within SA, which 
make interpreting low PDRs and ADRs difficult. 
Conclusions 
The audit of the WDGMC OEU revealed that 77.6% of outpatients 
had adequate bowel preparation, the CIR was 97.0% overall, and 
96.3% for screening colonoscopies. The median withdrawal time 
for negative-result screening colonoscopies was 5.7 minutes. For 
screening colonoscopies, the PDR and ADR were 27.6% and 15.6%, 
respectively, which are lower than benchmarks from HIC regions 
with a 3-fold higher incidence of CRC, yet relatively higher than 
rates reported from other sSA countries. While short withdrawal 
times might affect the PDR and ADR, the validity of using externally 
derived high-income population benchmarks in SA deserves scrutiny. 
Given there are no standardised national benchmarks and guidelines 
on colonoscopy in SA, we hope these data will contribute to 
developing local guidelines. Annual auditing of clinical practice, and 
these data thus being available in the public domain, will be standard 
of care in our OEU, therefore making this year’s audit a baseline for 
longitudinal observation and assessing the impact of interventions, as 
highlighted in our recommendations. 
Recommendations
The clinicians have agreed to standardise education of patients 
regarding bowel preparation (with input from clinicians who achieve 
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good bowel preparation rates) on the choice of bowel preparation 
and the use of a validated bowel preparation score.[27] Although 
adequate bowel preparation may seem straightforward, increasing 
patient adherence may incur a cost, such as employing a nurse 
educator who would be responsible for proper education of patients.[28] 
Furthermore, increasing withdrawal time should be strongly considered 
as a straightforward and relatively low-cost intervention. Due to 
the resource-intense nature of recording histological results for 
calculation of the ADR, the creation of an average adenoma-to-polyp 
detection rate quotient for the OEU could be cost-effective and useful 
in determining ADR from PDR, without needing these results. This 
will be feasible in time, as data from each annual audit can be used 
as a local reference. 
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